ANG and nonpapillary renal cell carcinoma: ANG inhibitors (neutralizing antibodies or small chemical compounds blocking angiogenin nucleus translocation) have already been described to inhibit tumor growth in vitro and in vivo,45,59,63 but further studies in the context of ccRCC are needed to evaluate their therapeutic potential.